UBS Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,483,040
Closed -$4.51M 9514
2024
Q4
$4.51M Buy
1,483,040
+850,487
+134% +$2.59M ﹤0.01% 3075
2024
Q3
$3.28M Buy
632,553
+581,780
+1,146% +$3.02M ﹤0.01% 2624
2024
Q2
$130K Sell
50,773
-139,419
-73% -$358K ﹤0.01% 4855
2024
Q1
$936K Sell
190,192
-3,961
-2% -$19.5K ﹤0.01% 3598
2023
Q4
$1.71M Buy
194,153
+76,108
+64% +$669K ﹤0.01% 2990
2023
Q3
$1.35M Sell
118,045
-11,980
-9% -$137K ﹤0.01% 2866
2023
Q2
$3.29M Sell
130,025
-1,264
-1% -$32K ﹤0.01% 2251
2023
Q1
$4.23M Buy
131,289
+58,464
+80% +$1.88M ﹤0.01% 1982
2022
Q4
$1.34M Sell
72,825
-9,937
-12% -$183K ﹤0.01% 2895
2022
Q3
$2.23M Sell
82,762
-4,147
-5% -$112K ﹤0.01% 2276
2022
Q2
$1.2M Sell
86,909
-2,361
-3% -$32.6K ﹤0.01% 2756
2022
Q1
$1.74M Buy
89,270
+4,615
+5% +$90K ﹤0.01% 2766
2021
Q4
$1.38M Buy
84,655
+23,374
+38% +$381K ﹤0.01% 3185
2021
Q3
$1.71M Buy
61,281
+8,099
+15% +$226K ﹤0.01% 2864
2021
Q2
$1.58M Sell
53,182
-952
-2% -$28.2K ﹤0.01% 2914
2021
Q1
$1.51M Buy
54,134
+6,140
+13% +$172K ﹤0.01% 3004
2020
Q4
$1.36M Sell
47,994
-511
-1% -$14.5K ﹤0.01% 2926
2020
Q3
$1.22M Sell
48,505
-4,648
-9% -$117K ﹤0.01% 2798
2020
Q2
$1.3M Buy
53,153
+12,427
+31% +$303K ﹤0.01% 2619
2020
Q1
$603K Buy
40,726
+11,476
+39% +$170K ﹤0.01% 3053
2019
Q4
$474K Buy
29,250
+27,850
+1,989% +$451K ﹤0.01% 3938
2019
Q3
$18K Hold
1,400
﹤0.01% 5844
2019
Q2
$18K Buy
1,400
+184
+15% +$2.37K ﹤0.01% 5821
2019
Q1
$19K Buy
1,216
+768
+171% +$12K ﹤0.01% 5528
2018
Q4
$9K Sell
448
-1,617
-78% -$32.5K ﹤0.01% 6371
2018
Q3
$52K Sell
2,065
-1,383
-40% -$34.8K ﹤0.01% 5246
2018
Q2
$95K Buy
3,448
+854
+33% +$23.5K ﹤0.01% 4602
2018
Q1
$80K Buy
2,594
+214
+9% +$6.6K ﹤0.01% 4544
2017
Q4
$85K Buy
2,380
+46
+2% +$1.64K ﹤0.01% 4539
2017
Q3
$64K Buy
2,334
+1,823
+357% +$50K ﹤0.01% 4744
2017
Q2
$13K Buy
511
+500
+4,545% +$12.7K ﹤0.01% 5666
2017
Q1
$0 Sell
11
-1,041
-99% ﹤0.01% 6871
2016
Q4
$22K Sell
1,052
-844
-45% -$17.7K ﹤0.01% 5522
2016
Q3
$31K Buy
1,896
+1,385
+271% +$22.6K ﹤0.01% 5028
2016
Q2
$7K Hold
511
﹤0.01% 6095
2016
Q1
$9K Sell
511
-1,378
-73% -$24.3K ﹤0.01% 5884
2015
Q4
$64K Buy
1,889
+1,389
+278% +$47.1K ﹤0.01% 4562
2015
Q3
$15K Hold
500
﹤0.01% 5680
2015
Q2
$16K Sell
500
-157
-24% -$5.02K ﹤0.01% 5675
2015
Q1
$13K Sell
657
-648
-50% -$12.8K ﹤0.01% 5716
2014
Q4
$22K Buy
+1,305
New +$22K ﹤0.01% 5457